PHASE II ONCE-WEEKLY ALENDRONATE IN HIV-INFECTED SUBJECTS WITH DECREASED BONE D

II 期每周一次阿仑膦酸钠用于骨 D 减少的 HIV 感染者

• 批准号: 7625543
• 负责人: DAVID A WOHL
• 金额: $ 0.11万
• 依托单位: UNIV OF NORTH CAROLINA CHAPEL HILL
• 依托单位国家: 美国
• 财政年份: 2006
• 资助国家: 美国
• 起止时间: 2006-12-01 至 2007-11-30
• 项目状态: 已结题
• 来源: https://reporter.nih.gov/project-details/7625543
• 关键词: Alendronate; Calcium; Computer Retrieval of Information on Scientific Projects Database; Funding; Grant; HIV Infections; Institution; Personal Satisfaction; Persons; Phase; Purpose; Research; Research Personnel; Resources; Source; United States National Institutes of Health; Vitamin D; bone; bone loss

This subproject is one of many research subprojects utilizing the resources provided by a Center grant funded by NIH/NCRR. The subproject and investigator (PI) may have received primary funding from another NIH source, and thus could be represented in other CRISP entries. The institution listed is for the Center, which is not necessarily the institution for the investigator. The main purpose of this study is to find out if alendronate plus calcium and vitamin D is well tolerated, effective and safe to treat bone loss in persons with HIV infection compared to calcium and vitamin D alone.

这个子项目是众多研究子项目之一